UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial

The lancet oncology, 2013-09, Vol.14 (10), p.1020-1026

2013

Volltextzugriff (PDF)

Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial

The Lancet (British edition), 2009-10, Vol.374 (9698), p.1331-1338

2009

Volltextzugriff (PDF)

Molecular Diagnosis and Targeting for Gynecologic Malignancy

1, 2021

Volltextzugriff (PDF)

Establishment and Genetic Profiling of Platinum/Taxane Doublet-Resistant Cells Generated by Hybridizing Single Resistant Cells

Clinical and experimental obstetrics & gynecology, 2022-10, Vol.49 (10), p.229

2022

Volltextzugriff (PDF)

Prognostic significance of Ki67 during neoadjuvant chemotherapy in primary unresectable ovarian cancer

The journal of obstetrics and gynaecology research, 2021-11, Vol.47 (11), p.3979-3989

2021

Volltextzugriff (PDF)

Indoleamine 2,3-Dioxygenase Serves as a Marker of Poor Prognosis in Gene Expression Profiles of Serous Ovarian Cancer Cells

Clinical cancer research, 2005-08, Vol.11 (16), p.6030-6039

2005

Volltextzugriff (PDF)

Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors

Japanese journal of clinical oncology, 2017-01, Vol.47 (1), p.32-38

2017

Volltextzugriff (PDF)

Safety and Effectiveness of an Enzyme-Targeting Radiosensitization Agent (KORTUC II) to Treat Uterine Cervical Cancer

Jikeikai Medical Journal, 2022-12, Vol.69 (4), p.75-83

2022

Volltextzugriff (PDF)

Clinical associations of Trousseau's syndrome associated with cerebral infarction and ovarian cancer

Journal of Gynecologic Oncology, 2018, 29(5), , pp.1-8

2018

Volltextzugriff (PDF)

Retrospective analysis of sites of recurrence in stage I epithelial ovarian cancer

Journal of Gynecologic Oncology, 2018, 29(3), , pp.1-11

2018

Volltextzugriff (PDF)

Readministration of Platinum Agents in Recurrent Ovarian Cancer Patients Who Developed Hypersensitivity Reactions to Carboplatin

In vivo (Athens), 2019-11, Vol.33 (6), p.2045-2050

2019

Volltextzugriff (PDF)

Establishment and characterization of a clear cell carcinoma cell line, designated NOCC, derived from human ovary

Human cell : official journal of Human Cell Research Society, 2016-10, Vol.29 (4), p.188-196

2016

Volltextzugriff (PDF)

Diagnostic Value of Cell Block Method in Ascites Fluid of Ovarian Cancer

Journal of clinical and diagnostic research, 2020-03, Vol.14 (3), p.QC01-QC04

2020

Volltextzugriff (PDF)

Possible involvement of glycolipids in anticancer drug resistance of human ovarian serous carcinoma-derived cells

Journal of biochemistry (Tokyo), 2012-12, Vol.152 (6), p.587-594

2012

Volltextzugriff (PDF)

Side population is increased in paclitaxel-resistant ovarian cancer cell lines regardless of resistance to cisplatin

Gynecologic oncology, 2011-05, Vol.121 (2), p.390-394

2011

Volltextzugriff (PDF)

Alpha-fetoprotein (AFP)-producing ovarian tumor in an elderly woman

International journal of clinical oncology, 2009-02, Vol.14 (1), p.70-73

2009

Volltextzugriff (PDF)

Concurrent high-grade serous carcinoma and borderline tumor demonstrating different chemo-sensitivity

International cancer conference journal, 2017-04, Vol.6 (2), p.65-69

2017

Volltextzugriff (PDF)

Stepwise increase of MIB-1 index in frequently relapsed malignant peritoneal mesothelioma

International cancer conference journal, 2017-04, Vol.6 (2), p.80-83

2017

Volltextzugriff (PDF)

Pathology-oriented treatment strategy of malignant ovarian tumor in pregnant women: analysis of 41 cases in Japan

International journal of clinical oncology, 2014-12, Vol.19 (6), p.1074-1079

2014

Volltextzugriff (PDF)

A feasibility study on maintenance of docetaxel after paclitaxel-carboplatin chemotherapy in patients with advanced ovarian cancer

Journal of Gynecologic Oncology, 2013, 24(2), , pp.154-159

2013

Volltextzugriff (PDF)

Analysis of prognostic factors for patients with leiomyoma treated with uterine arterial embolization

American journal of obstetrics and gynecology, 2008-03, Vol.198 (3), p.270.e1-270.e6

2008

Volltextzugriff (PDF)

Characterization of two independent, exposure-time dependent paclitaxel-resistant human ovarian carcinoma cell lines

Human cell : official journal of Human Cell Research Society, 2010-11, Vol.23 (4), p.156-163

2010

Volltextzugriff (PDF)

Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial

Journal of clinical oncology, 2016-08, Vol.34 (24), p.2881-2887

2016

Volltextzugriff (PDF)

Small cell carcinoma of the ovary: clinical and biological study

International journal of clinical oncology, 2008-04, Vol.13 (2), p.161-165

2008

Volltextzugriff (PDF)

Differential regulation of the cytotoxicity activity of paclitaxel by orobol and platelet derived growth factor in human ovarian carcinoma cells

Oncology reports, 2007-07, Vol.18 (1), p.195-201

2007

Volltextzugriff (PDF)

1 – 25 von 122

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(103)

Publikationsform

Artikel
(105)
Buchkapitel
(13)
Berichte
(3)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(59)
Science & Technology
(59)
Humans
(57)
Female
(49)
Oncology
(36)
Ovarian Cancer
(25)
Ovarian Neoplasms - Pathology
(23)
Ovarian Neoplasms - Drug Therapy
(22)
Chemotherapy
(20)
Biological And Medical Sciences
(19)
Medical Sciences
(18)
Adult
(16)
Middle Aged
(16)
Obstetrics & Gynecology
(14)
Tumors
(14)
Aged
(11)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(11)
Cisplatin - Pharmacology
(11)
Tumor Cells, Cultured
(11)
Case Report
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial

Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial

Molecular Diagnosis and Targeting for Gynecologic Malignancy

Establishment and Genetic Profiling of Platinum/Taxane Doublet-Resistant Cells Generated by Hybridizing Single Resistant Cells

Prognostic significance of Ki67 during neoadjuvant chemotherapy in primary unresectable ovarian cancer

Indoleamine 2,3-Dioxygenase Serves as a Marker of Poor Prognosis in Gene Expression Profiles of Serous Ovarian Cancer Cells

Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors

Safety and Effectiveness of an Enzyme-Targeting Radiosensitization Agent (KORTUC II) to Treat Uterine Cervical Cancer

Clinical associations of Trousseau's syndrome associated with cerebral infarction and ovarian cancer

Retrospective analysis of sites of recurrence in stage I epithelial ovarian cancer

Readministration of Platinum Agents in Recurrent Ovarian Cancer Patients Who Developed Hypersensitivity Reactions to Carboplatin

Establishment and characterization of a clear cell carcinoma cell line, designated NOCC, derived from human ovary

Diagnostic Value of Cell Block Method in Ascites Fluid of Ovarian Cancer

Possible involvement of glycolipids in anticancer drug resistance of human ovarian serous carcinoma-derived cells

Side population is increased in paclitaxel-resistant ovarian cancer cell lines regardless of resistance to cisplatin

Alpha-fetoprotein (AFP)-producing ovarian tumor in an elderly woman

Concurrent high-grade serous carcinoma and borderline tumor demonstrating different chemo-sensitivity

Stepwise increase of MIB-1 index in frequently relapsed malignant peritoneal mesothelioma

Pathology-oriented treatment strategy of malignant ovarian tumor in pregnant women: analysis of 41 cases in Japan

A feasibility study on maintenance of docetaxel after paclitaxel-carboplatin chemotherapy in patients with advanced ovarian cancer

Analysis of prognostic factors for patients with leiomyoma treated with uterine arterial embolization

Characterization of two independent, exposure-time dependent paclitaxel-resistant human ovarian carcinoma cell lines

Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial

Small cell carcinoma of the ovary: clinical and biological study

Differential regulation of the cytotoxicity activity of paclitaxel by orobol and platelet derived growth factor in human ovarian carcinoma cells

Suchergebnisse filtern